Fosun International LTD Cytom X Therapeutics, Inc. Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$7.38 - $12.25 $719,232 - $1.19 Million	-97,457 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$9.35 - $11.41 $420,862 - $513,586	45,012 Added 85.83%	97,457 $1.04 Million
Q1 2019 May 10, 2019	BUY	$9.5 - $19.16 $163,400 - $329,552	17,200 Added 48.8%	52,445 $551,000
Q4 2018 Jan 31, 2019	BUY	$12.69 - $18.61 $447,259 - $655,909	35,245 New	35,245 $517,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $75.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.